Drs. Anshel Kenkare and Mike Reid share a conversation about the incredible science and current context of lenacapavir for HIV prevention, which was recently approved by the FDA.<a href="https://febrilepodcast.com/episodes/" rel="noopener noreferrer" target="_blank">Episodes</a> | <a href="https://febrilepodcast.com/consult-notes/" rel="noopener noreferrer" target="_blank">Consult Notes</a> | <a href="https://febrilepodcast.captivate.fm/listen" rel="noopener noreferrer" target="_blank">Subscribe</a> | <a href="https://twitter.com/febrilepodcast" rel="noopener noreferrer" target="_blank">Twitter</a> | <a href="https://febrile.bigcartel.com/" rel="noopener noreferrer" target="_blank">Merch</a> | <a href="mailto:febrilepodcast@gmail.com" rel="noopener noreferrer" target="_blank">febrilepodcast@gmail.com</a>Febrile is produced with support from the Infectious Diseases Society of America (IDSA)

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

123: Lenacapavir for HIV Prevention

Febrile

AI Chapters

AI Insights

Reviews